School of Medicine

The university will celebrate its 1853 founding during the Founders Day gala Nov. 3 at the St. Louis Union Station Hotel. The keynote speaker is Robert Gates, former U.S. defense secretary. At the event, WUSTL will honor distinguished faculty, alumni and Robert S. Brookings award recipients.

School of Medicine researchers have received a five-year, $2.7 million grant to detect and analyze differences in the brains of children with a rare illness, Wolfram syndrome. The disorder includes a severe form of diabetes, hearing and vision loss and kidney problems. Patients also eventually lose muscle control and coordination from brain degeneration.

A series of application workshops will be held for students interested in the Clinton Global Initiative University (CGI U) to be held at Washington University in St. Louis April 5-7, 2013. The workshops will focus on application criteria and developing the required Commitment to Action. A Commitment to Action is a concrete plan that addresses a pressing challenge in one of CGI U’s five focus areas: education, environment and climate change, peace and human rights, poverty alleviation, or public health. The first workshop will be held from 6:30-7:30 p.m. Thursday, Nov. 1, in Brown Hall, Room 118. 

Resveratrol, an ingredient in red wine thought to improve insulin sensitivity, reduce risk of heart disease and increase longevity, does not appear to have those benefits in healthy women, according to new research from Washington University School of Medicine in St. Louis.

Ross Brownson, PhD, professor of medicine and social work at Washington University in St. Louis, has been named president-elect of the American College of Epidemiology.

​Larry J. Shapiro, MD, executive vice chancellor for medical affairs and dean of the School of Medicine, will host the annual Dean’s Update for all employees Nov. 7 and 9.

​Charles E. Canter, MD, has been named the first Lois B. Tuttle and Jeanne B. Hauck Chair in Pediatrics at St. Louis Children’s Hospital and Washington University School of Medicine in St. Louis.

Researchers at Washington University School of Medicine in St. Louis have found a key difference in the brains of people with Alzheimer’s disease and those who are cognitively normal but still have the brain plaques that characterize this type of dementia.

They said it couldn’t be done. Suresh Vedantham, MD, professor of radiology and surgery, was planning a nationwide trial comparing treatments for deep vein thromboses — dangerous blood clots in the legs’ major veins. Prior attempts had failed to meet recruitment goals, but Vedantham was eager to test a new approach. Four years later, recruitment for ATTRACT (Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis), his NIH-sponsored trial, has crossed the halfway mark.

​​Washington University School of Medicine in St. Louis will host a half-day seminar on forms of dementia that strike suddenly and can kill an individual in a few weeks or months.​